Human Inducible Pluripotent Stem Cells and Autism Spectrum Disorder: Emerging Technologies
The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Abstract
Autism Spectrum Disorder (ASD) is a behaviorally defined neurodevelopmental condition. Symptoms of ASD cover the spectrum from mild qualitative differences in social interaction to severe communication and social and behavioral challenges that require lifelong support. Attempts at understanding the pathophysiology of ASD have been hampered by a multifactorial etiology that stretches the limits of current behavioral and cell based models. Recent progress has implicated numerous autism‐risk genes but efforts to gain a better understanding of the underlying biological mechanisms have seen slow progress. This is in part due to lack of appropriate models for complete molecular and pharmacological studies. The advent of induced pluripotent stem cells (iPSC) has reinvigorated efforts to establish more complete model systems that more reliably identify molecular pathways and predict effective drug targets and candidates in ASD. iPSCs are particularly appealing because they can be derived from human patients and controls for research purposes and provide a technology for the development of a personalized treatment regimen for ASD patients. The pluripotency of iPSCs allow them to be reprogrammed into a number of CNS cell types and phenotypically screened across many patients. This quality is already being exploited in protocols to generate 2‐dimensional (2‐D) and three‐dimensional (3‐D) models of neurons and developing brain structures. iPSC models make powerful platforms that can be interrogated using electrophysiology, gene expression studies, and other cell‐based quantitative assays. iPSC technology has limitations but when combined with other model systems has great potential for helping define the underlying pathophysiology of ASD. Autism Res 2016, 9: 513–535 . © 2015 International Society for Autism Research, Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Direct conversion of fibroblasts to functional neurons by defined factors
Vierbuchen, T., Ostermeier, A., Pang, Z. P., Kokubu, Y., Südhof, T. C., & Wernig, M. (2010) · Nature · doi:10.1038/nature08797 · Cited by 3,017 · cited 2×
“…protocols that do not use dualSMAD inhibition to derive cortical neurons that include: activation of the Wnt and SHH pathways, and the direct conversion of fibroblasts into neurons by forced expression of neurogenin-2, among others [Li et al., 2009; Vierbuchen et al., 2010; Zhang et al., 2013].”
BackgroundThe contribution of de novo coding mutations to autism spectrum disorder
Iossifov, I., O’Roak, B. J., Sanders, S. J., Ronemus, M., Krumm, N., Levy, D., Stessman, H. A., Witherspoon, K. T., Vives, L., Patterson, K. E., et al. (2014) · Nature · doi:10.1038/nature13908 · Cited by 2,585 · cited 2×
“Although a number of genes have been implicated in ASD, many de novo mutations can contribute to the ASD phenotype [Iossifov et al., 2014].”
BackgroundFMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism
Darnell, J. C., Van Driesche, S. J., Zhang, C., Hung, K. Y. S., Mele, A., Fraser, C. E., Stone, E. F., Chen, C., Fak, J. J., Chi, S. W., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.013 · Cited by 2,072 · cited 2×
“5% of those with ASD and is also found in ASD-related conditions Fragile-X syndrome and tuberous sclerosis [Darnell et al., 2011; Durand et al., 2006; Moessner et al., 2007; Gauthier et al., 2009; Sakai et al., 2011; Soorya et al., 2013].”
BackgroundInfluentialFunctional impact of global rare copy number variation in autism spectrum disorders
Pinto, D., Pagnamenta, A. T., Klei, L., Anney, R., Merico, D., Regan, R., Conroy, J., Magalhaes, T. R., Correia, C., Abrahams, B. S., et al. (2010) · Nature · doi:10.1038/nature09146 · Cited by 2,013 · cited 1×
“One such study evaluated over 3,000 genes with an ASD link and found that copy number variants (CNV) tended to occur in genes involved in cell proliferation, cell motility and GTPASE/RAS signaling [Pinto et al., 2010].”
BackgroundGenetic Heritability and Shared Environmental Factors Among Twin Pairs With Autism
Hallmayer, J. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.76 · Cited by 1,970 · cited 1×
“The NCI-60 paradigm can guide development of iPSC cell-based assays for ASD as, like cancer, there are multiple factors that contribute to development of the ASD phenotype [Bill & Geschwind, 2009; Hallmayer et al., 2011].”
MethodMeCP2, a Key Contributor to Neurological Disease, Activates and Represses Transcription
Chahrour, M., Jung, S. Y., Shaw, C., Zhou, X., Wong, S. T. C., Qin, J., & Zoghbi, H. Y. (2008) · Science · doi:10.1126/science.1153252 · Cited by 1,823
The development and application of optogenetics
Fenno, L., Yizhar, O., & Deisseroth, K. (2011) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113817 · Cited by 1,822 · cited 1×
“[Chen et al., 2013; Fenno et al., 2011; Grienberger & Konnerth, 2012; Jin et al., 2012; Kuner & Augustine, 2000; Mancuso et al., 2010] Voltage-Sensitive Dyes Can use optical techniques to record membrane voltage changes in a high-throughput platform.”
A conditional knockout resource for the genome-wide study of mouse gene function
Skarnes, W. C., Rosen, B., West, A. P., Koutsourakis, M., Bushell, W., Iyer, V., Mujica, A. O., Thomas, M., Harrow, J., Cox, T., et al. (2011) · Nature · doi:10.1038/nature10163 · Cited by 1,708
Rapid single-step induction of functional neurons from human pluripotent stem cells
Zhang, Y., Pak, C., Han, Y., Ahlenius, H., Zhang, Z., Chanda, S., Marro, S., Patzke, C., Acuna, C., Covy, J., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.05.029 · Cited by 1,644 · cited 2×
“…protocols that do not use dualSMAD inhibition to derive cortical neurons that include: activation of the Wnt and SHH pathways, and the direct conversion of fibroblasts into neurons by forced expression of neurogenin-2, among others [Li et al., 2009; Vierbuchen et al., 2010; Zhang et al., 2013].”
BackgroundFunctional cortical neurons and astrocytes from human pluripotent stem cells in 3D culture
Paşca, A. M., Sloan, S. A., Clarke, L. E., Tian, Y., Makinson, C. D., Huber, N., Kim, C. H., Park, J.-Y., O'Rourke, N. A., Nguyen, K. D., et al. (2015) · Nature Methods · doi:10.1038/nmeth.3415 · Cited by 1,609 · cited 3×
“D culture system that revealed cortical lamination with a ventral zone, superficial and deep layers expressing TBR1, BRN2, SATB2, and CTIP2 at day 135 [Pasca et al., 2015].”
BackgroundInfluential
Cited by
Current perspectives in autism spectrum disorder: from genes to therapy
Chahrour, M., O'Roak, B. J., Santini, E., Samaco, R. C., Kleiman, R. J., & Manzini, M. C. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.2335-16.2016 · Cited by 54
Development and Characterization of Human Cerebral Organoids: An Optimized Protocol
Yakoub, A. M., & Sadek, M. (2018) · Cell Transplantation · doi:10.1177/0963689717752946 · Cited by 47
Flaherty, E. K., & Brennand, K. J. (2017) · Brain Research · doi:10.1016/j.brainres.2015.11.009 · Cited by 19
Metadata
- Authors
- Nestor, M. W., Phillips, A. W., Artimovich, E., Nestor, J. E., Hussman, J. P., & Blatt, G. J.
- Venue
- Autism Research
- Publisher
- Wiley
- Published
- 2015-10
- Volume
- 9
- Issue
- 5
- Pages
- 513-535
- ISSN
- 1939-3792 (ISSN-L)
- 1939-3806
- OpenAlex
- W1833799144
- Cited by
- 35
- References
- 61
- FWCI
- 2.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.